Provocation tests as measure of efficacy and dosage

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue SUPPL. 95, 2011, Pages 47-49

  De Blay, F ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Allergen chamber; allergen diagnosis; allergen provocation test; therapeutic efficacy

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAT ALLERGEN; CORTICOSTEROID; DER P 1 ALLERGEN; FEL D 1 ALLERGEN; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PREDNISONE; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; THEOPHYLLINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOXANE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; DOMESTIC ANIMAL ALLERGY; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; FALSE POSITIVE RESULT; HUMAN; IMMUNOPATHOLOGY; INHALATION TEST; NONHUMAN; NOSE PROVOCATION TEST; PARTICLE SIZE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROVOCATION TEST; SERODIAGNOSIS; STANDARDIZATION;

ALLERGENS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL PROVOCATION TESTS; HUMANS; TREATMENT OUTCOME;

EID: 79958799245     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02634.x     Document Type: Article

References (14)

1. Committee for Medicinal Products for Human Use. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases 2008.
2. Lieutier-Colas F, Purohit A, Meyer P, Fabries JF, Kopferschmitt MC, Dessanges JF, et al., Bronchial challenge tests in patients with asthma sensitized to cats: the importance of large particles in the immediate response. Am J Respir Crit Care Med 2003; 167: 1077-1082. (Pubitemid 36459652)
3. Casset A, Marchand C, Purohit A, le Calve S, Uring-Lambert B, Donnay C, et al., Inhaled formaldehyde exposure: effect on bronchial response to mite allergen in sensitized asthma patients. Allergy 2006; 61: 1344-1350. (Pubitemid 44465596)
4. Sakaguchi M, Inouye S, Yasueda H, Irie T, Yoshizawa S, Shida T,. Measurement of allergens associated with dust mite allergy. II. Concentrations of airborne mite allergens (Der I and Der II) in the house. Int Arch Allergy Appl Immunol 1989; 90: 190-193. (Pubitemid 19270536)
5. de Blay F, Heymann PW, Chapman MD, Platts-Mills TA,. Airborne dust mite allergens: comparison of group II allergens with group I mite allergen and cat-allergen Fel d I. J Allergy Clin Immunol 1991; 88: 919-926.
6. de Blay F, Barnig C, Purohit A,. Cat and Dog Allergy. In:, Vijay HM, Kurup VP, editors. Recent Trends in Aerobiology, Allergy, and Immunology. Kerala: Research Signpost, 2009;333.
7. O'Byrne PM, Gauvreau GM, Brannan JD,. Provoked models of asthma: what have we learnt? Clin Exp Allergy 2009; 39: 181-192.
8. Boulet L-P, Gauvreau G, Boulay M, O'Byrne P, Cockcroft D,. The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy 2007; 62: 1101-1110. (Pubitemid 47374030)
9. Gosepath J, Amedee RG, Mann WJ,. Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. Laryngoscope 2005; 115: 512-516. (Pubitemid 40328003)
10. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, et al., Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology. Laryngorhinootologie 2003; 82: 183-188. (Pubitemid 36437662)
11. Alvarez-Cuesta E, Berges-Gimeno P, Gonzalez-Mancebo E, Fernandez-Caldas E, Cuesta-Herranz J, Casanovas M,. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study. Allergy 2007; 62: 810-817. (Pubitemid 46934367)
12. Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ,. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy 1997; 27: 860-867. (Pubitemid 27359850)
13. Day JH, Horak F, Briscoe MP, Canonica GW, Fineman SM, Krug N, et al., The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper. Clin Exp Allergy Rev 2006; 6: 31-59.
14. Krug N, Hohlfeld JM, Geldmacher H, Larbig M, Heermann R, Lavallee N, et al., Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy 2005; 60: 354-359. (Pubitemid 40293353)